Cesar de la Fuente
Tracked across 1 events · 23 articles · First seen Jun 30, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Cesar de la Fuente led the UPenn validation study of EDEN-designed antibiotics, highlighting academic collaboration.
Jun 30, 2026 · 23 articles
ERGEN INTELLIGENCE
Track Cesar de la Fuente live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard